Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted vs Non-Adjuvanted Influenza Vaccines in the Elderly
NCT06676644Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2024
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of MF59-adjuvanted quadrivalent influenza vaccine in influenza (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Seroconversion Rate at Day 29. Started Nov 2024; status: recruiting.
02
Drugs
MF59-adjuvanted quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06676644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06676644.